ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Hendrik Tevaearai Stahel
Hendrik T. Tevaearai Stahel, M.D. EMBA-HSG
Background
Regular school in Strasbourg (F), Tahiti and Yverdon (CH)
Lausanne Medical School (MD 1992)
Swiss Institute for Cancer Research (1988-1990)
Lausanne General Surgery Residency (1990-1995)
Lausanne Cardiovascular Surgery Residency (1995-2003)
Duke Medical center, Research Fellowship (1999-2001)
Berne Cardiovascular Surgery (2003 - 2006)
Berne Cardiovascular Surgery Research (2003 - 2016)
eMBA University of St-Gallen (2006-2007)
CEO Swiss Cardio Technologies (2008 - 2024)
President, Swiss Transplantation Society (2022 - 2024)
CEO HerzZentrum Hirslanden Zürich (2023 - today)
Other Interests
Myocardial protection
Cardioplegic solutions
Preservation solutions
General cardiac surgery (adult)
Minimally invasive cardiac surgery
Heart failure
Tissue engineering, Reperfusion injury
Microtechnology, Sensors
New technologies in cardiac therapeutics
Virtual reality
Printer-friendlyPractice Areas
- Cardiac
- Vascular
- Coronary disease
- Extracorporeal circulation
- Heart failure
- Mechanical circulatory assistance
- Heart Transplant
- Professional Affairs
- Ethics
- Medical technology
- Basic science